Tempo Scan Pacific Tbk PT
IDX:TSPC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 750
2 840
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Tempo Scan Pacific Tbk PT
Cash & Cash Equivalents
Tempo Scan Pacific Tbk PT
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Cash & Cash Equivalents
Rp64.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
23%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Cash & Cash Equivalents
Rp3.7T
|
CAGR 3-Years
-7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Cash & Cash Equivalents
Rp437.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
42%
|
CAGR 10-Years
26%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Cash & Cash Equivalents
Rp470.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Cash & Cash Equivalents
Rp505.4B
|
CAGR 3-Years
129%
|
CAGR 5-Years
216%
|
CAGR 10-Years
70%
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Cash & Cash Equivalents
Rp505.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
13%
|
|
Tempo Scan Pacific Tbk PT
Glance View
PT Tempo Scan Pacific Tbk engages in the pharmaceutical business. The company is headquartered in Jakarta, Dki Jakarta and currently employs 4,725 full-time employees. The firm has three core business divisions: pharmaceutical division, consumer products and cosmetics division and distribution division. Its pharmaceutical division manufactures and markets various over-the-counter (OTC) and ethical drugs as well as supplements. Its manufacturing plants are located in Bekasi, Indonesia. Its consumer products and cosmetics division manufactures and markets various consumer products, such as soap, household products and cosmetics. Its manufacturing plants are located in Pulogadung, Bekasi and Surabaya, Indonesia. Its distribution division distributes its products and third-party products. Its subsidiaries include PT Supra Ferbindo, PT Tempo Rx Farma, PT Tempo Nagadi, PT Rudy Soetadi, PT Perusahaan Dagang Tempo and PT Supra Usadhatama.
See Also
What is Tempo Scan Pacific Tbk PT's Cash & Cash Equivalents?
Cash & Cash Equivalents
64.6B
IDR
Based on the financial report for Sep 30, 2024, Tempo Scan Pacific Tbk PT's Cash & Cash Equivalents amounts to 64.6B IDR.
What is Tempo Scan Pacific Tbk PT's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
23%
Over the last year, the Cash & Cash Equivalents growth was -33%. The average annual Cash & Cash Equivalents growth rates for Tempo Scan Pacific Tbk PT have been -21% over the past three years , -2% over the past five years , and 23% over the past ten years .
You don't have any saved screeners yet
